Motilal Oswal Private Equity (MOPE) and Rosewood Investments, the private equity arm of The Rosewood Corporation, have bought out private equity major Actis’ 70 per cent holding in Symbiotec Pharmalab Pvt Ltd, according to an announcement on Tuesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com